Synthorx
Synthorx is a Clinical Stage Biotechnology company. It is focused on prolonging and improving the lives of people with cancer and autoimmune disorders and platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics referred to as Synthorins. The headquarters is in USA.
Assore delisted from JSE in March-2020.